Aaron R. Sasson, MD — Academic Profile

I am a surgical oncologist specializing in the treatment of gastrointestinal malignancies. I have a special interest in pancreatic cancers, with focus on early detection, screening, surgical management, and adjuvant therapy. My surgical experience with upper gastrointestinal disease includes both traditional open techniques as well as more advanced minimally invasive approaches. My research interests include the utilization of blood tests to help detect pancreatic cancer early, ways to stratify risk for pancreatic cystic lesions, and development of a screening program for pancreatic cancer.

• Attending of the Year Award, Graduating Residents, Department of Surgery, Stony Brook Medicine (2017)
• Nurses Choice Award, Stony Brook University Hospital (2017)
• Selected for inclusion in the Castle Connolly Guide, America's Top Doctors, representing the top 1% of physicians in the nation
• Selected for inclusion in the Castle Connolly Guide, America's Top Doctors for Cancer
• Selected for the Best Doctors in America database
• Patients' Choice Award (Vitals), 2011-12
• UNMC Pancreatic Cancer Spore Career Development Award, 2002
• American Society of Clinical Oncology Merit Award, 2001
• Aventis Scholarship Program, 2001
• Outstanding Teaching Award, Department of Surgery, University of California, San Diego Medical Center, 1999
• Chairman's Prize, Department of Surgery, University of California, San Diego Medical Center, 1999
• Winner, Resident Presentation, San Diego Society of General Surgeons, 1998

• My current research interests are in early diagnostic tests for pancreatic cancer and multimodality treatment of pancreatic and biliary malignancies.

• > Click here to see abstracts/full text of Dr. Sasson's journal articles on PubMed (National Library of Medicine).
• Ahmed SI, Bochkarev V, Oleynikov D, Sasson AR. Patients with pancreatic adenocarcinoma benefit from staging laparoscopy. J Laparoendosc Adv Surg Tech A 2006;16:458-63.
• Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, et al.; NCCN Gastric Cancer Panel. Gastric cancer. J Natl Compr Canc Netw 2010;8:378-409.
• Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, et al.; NCCN Esophageal Cancer Panel. Esophageal cancer. J Natl Compr Canc Netw 2008;6:818-49.
• Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, et al.; National Comprehensive Cancer Network. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 2011;9:830-87.
• Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs C, Gibson MK, Goldberg M, Hayman JA, Ilson DH, Javle M, Kelley S, Kurtz RC, Locker GY, Meropol NJ, Minsky BD, Orringer MB, Osarogiagbon RU, Posey JA, Roth J, Sasson AR, et al. Gastric cancer clinical practice guidelines. J Natl Compr Canc Netw 2006;4:350-66.
• Ajani J, Bekaii-Saab T, D'Amico TA, Fuchs C, Gibson MK, Goldberg M, Hayman JA, Ilson DH, Javle M, Kelley S, Kurtz RC, Locker GY, Meropol NJ, Minsky BD, Orringer MB, Osarogiagbon RU, Posey JA, Roth J, Sasson AR, et al. Esophageal cancer clinical practice guidelines. J Natl Compr Canc Netw 2006;4:328-47.
• Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, et al.; National Comprehensive Cancer Network. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2013;11:531-46.
• Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, et al. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw 2015;13:194-227.
• Anderson MA, Zolotarevsky E, Cooper KL, Sherman S, Shats O, Whitcomb DC, Lynch HT, Ghiorzo P, Rubinstein WS, Vogel KJ, Sasson AR, et al. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Am J Gastroenterol 2012;107:1730-9.
• Are C, Afuh C, Ravipati L, Sasson A, Ullrich F, Smith L. Preoperative nomogram to predict risk of perioperative mortality following pancreatic resections for malignancy. J Gastrointest Surg 2009;13:2152-62.
• Are C, Ly Q, Sasson AR. Primum non nocere, or leave that ostomy alone: Comment on "Incisional hernias in temporary stoma wounds." Arch Surg 2011;146:99-100.
• Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE, Batra SK. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. PLoS One 2011;6:e17014.
• Baine MJ, Menning M, Smith LM, Mallya K, Kaur S, Rachagani S, Chakraborty S, Sasson AR, Brand RE, Batra SK. Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Cancer Biomark 2011-2012;11:1-14.
• Benson AB, Myerson RJ, Sasson A. Pancreatic, neuroendocrine GI, and adrenal cancers. In: Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ, editors. Cancer Management: A Multidisciplinary Approach. 12th ed. Norwalk CT: UBM Medica, 2010.
• Bruzoni M, Johnston E, Sasson AR. Pancreatic incidentalomas: clinical and pathologic spectrum. Am J Surg 2008;195:329-32.
• Bruzoni M, Parikh P, Celis R, Are C, Ly QP, Meza JL, Sasson AR. Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review. Am J Surg 2009;197:376-81.
• Bruzoni M, Sasson AR. Open and laparoscopic spleen-preserving, splenic vessel-preserving distal pancreatectomy: indications and outcomes. J Gastrointest Surg 2008;12:1202-6.
• Cathcart SJ, Sasson AR, Kozel JA, Oliveto JM, Ly QP. Duodenal gangliocytic paraganglioma with lymph node metastases: a case report and comparative review of 31 cases. World J Clin Cases 2017;5:222-33.
• Chakraborty S, Baine MJ, Sasson AR, Batra SK. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochim Biophys Acta 2011;1815:44-64.
• Chakraborty S, Jain M, Sasson AR, Batra SK. MUC4 as a diagnostic marker in cancer. Expert Opin Med Diagn 2008;2:891-910.
• Demetri GD, Baker LH, Benjamin RS, Casper ES, Conrad EU 3rd, D'Amato GZ, DeLaney TF, Ettinger DS, Heck R Jr, Heslin MJ, Hutchinson RJ, Jacobs CD, Kiel K, Kraybill WG, Letson GD, O'Donnell RJ, Paz IB, Pfeifer J, Pollock RE, Randall RL, Sasson AR, et al.; National Comprehensive Cancer Network. Soft tissue sarcoma. J Natl Compr Canc Netw 2007;5:364-99.
• Dhir M, Sasson AR. Surgical management of liver metastases from colorectal cancer. J Oncol Pract 2016;12:33-9.
• Dhir M, Smith LM, Ullrich F, Leiphrakpam PD, Ly QP, Sasson AR, Are C. A preoperative nomogram to predict the risk of perioperative mortality following gastric resections for malignancy. J Gastrointest Surg 2012;16:2026-36.
• Dhir M, Smith LM, Ullrich F, Leiphrakpam PD, Ly QP, Sasson AR, Are C. Pre-operative nomogram to predict risk of peri-operative mortality following liver resections for malignancy. J Gastrointest Surg 2010;14:1770-81.
• Gao M, Lin M, Moffitt RA, Salazar MA, Park J, Vacirca J, Huang C, Shroyer KR, Choi M, Georgakis GV, Sasson AR, Talamini MA, Kim J. Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer. Br J Cancer 2019;120:88-96.
• Gleason MX, Mdzinarishvili T, Are C, Sasson A, Sherman A, Shats O, Sherman S. Prognostic estimator of survival for patients with localized and extended pancreatic ductal adenocarcinoma. Cancer Inform 2013;12:103-14.
• Goldberg M, Gupta D, Sasson AR, Movsas B, Langer CJ, Hanlon AL, Wang H, Scott WJ. The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up. Ann Thorac Surg 2005;79:1174-9.
• Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE. Definitive characterization of CA 19-9 in resectable pancreatic cancer using a reference set of serum and plasma specimens. PLoS One 2015;10:e0139049.
• Kaur S, Chakraborty S, Baine MJ, Mallya K, Smith LM, Sasson A, Brand R, Guha S, Jain M, Wittel U, Singh SK, Batra SK. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. PLoS One 2013;8:e55171.
• Kaur S, Baine MJ, Guha S, Ochi N, Chakraborty S, Mallya K, Thomas C, Crook J, Wallace MB, Woodward TA, Jain M, Singh S, Sasson AR, Skinner V, Raimondo M, Batra SK. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas. Pancreas 2013;42:494-501.
• Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med 2012;6:597-612.
• Kaur S, Kumar S, Momi N, Sasson AR, Batra SK. Mucins in pancreatic cancer and its microenvironment. Nat Rev Gastroenterol Hepatol 2013;10:607-20.
• Kaur S, Sharma N, Krishn SR, Lakshmanan I, Rachagani S, Baine MJ, Smith LM, Lele SM, Sasson AR, Guha S, Mallya K, Anderson JM, Hollingsworth MA, Batra SK. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. Clin Cancer Res 2014;20:688-700.
• Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, Krishn SR, Mallya K, Aithal A, Sasson AR, et al. A combination of MUC5AC and CA19-9 improves the diagnosis of pancreatic cancer: a multicenter study. Am J Gastroenterol 2017;112:172-83.
• Ly QP, Sasson AR. Modern surgical considerations for gastric cancer. J Natl Compr Canc Netw 2008;6:885-94.
• Mathews K, Sasson A, Cohen S. Pathologic quiz case: a woman with abdominal fullness. Adrenal myelolipoma. Arch Pathol Lab Med 2004;128:703-4.
• Meyers MO, Sasson AR, Sigurdson ER. Locoregional strategies for colorectal hepatic metastases. Clin Colorectal Cancer 2003;3:34-44.
• Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, Lele SM, Ouellette M, Pour PM, Sasson AR, Brand RE, Hollingsworth MA, Jain M, Batra SK. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 2008;98:1540-7.
• Pagkratis S, Kryeziu S, Lin M, Hoque S, Bucobo JC, Buscaglia JM, Georgakis GV, Sasson AR, Kim J. Case report of intestinal non-rotation, heterotaxy, and polysplenia in a patient with pancreatic cancer. Medicine (Baltimore) 2017;96:e8599.
• Pingpank JF, Hoffman JP, Ross EA, Cooper HS, Meropol NJ, Freedman G, Pinover WH, LeVoyer TE, Sasson AR, Eisenberg BL. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg 2001;5:121-30.
• Pingpank JF Jr, Hoffman JP, Sigurdson ER, Ross E, Sasson AR, Eisenberg BL. Pancreatic resection for locally advanced primary and metastatic nonpancreatic neoplasms. Am Surg 2002;68:337-41.
• Pingpank JF Jr, Sasson AR, Eisenberg BL. Surgical management of soft-tissue sarcomas. In: Markman M, editor. Atlas of Cancer. Philadelphia: Current Medicine, 2002.
• Pingpank JF Jr, Sasson AR, Hanlon AL, Friedman CD, Ridge JA. Tumor above the spinal accessory nerve in papillary thyroid cancer that involves lateral neck nodes: a common occurrence. Arch Otolaryngol Head Neck Surg 2002;128:1275-8.
• Ringley C, Lee YK, Iqbal A, Bocharev V, Sasson A, McBride CL, Thompson JS, Vitamvas ML, Oleynikov D. Comparison of conventional laparoscopic and hand-assisted oncologic segmental colonic resection. Surg Endosc 2007;21:2137-41.
• Sasson AR. Localized gastric cancer: chemoradiation is not always needed. Gastrointest Cancer Res 2009;3(2 Suppl):S22-5.
• Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 2001;91:1862-9.
• Sasson AR, Gamagami R, An Z, Wang X, Moossa AR, Hoffman RM. Cimetidine: an inhibitor or promoter of tumor growth? Int J Cancer 1999;81:835-8.
• Sasson AR, Gulizia JM, Galva A, Anderson J, Thompson J. Pancreaticoduodenectomy for suspected malignancy: have advancements in radiographic imaging improved results? Am J Surg 2006;192:888-93.
• Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg 2002;6:147-58.
• Sasson AR, Hoffman JP, Ross E, Meropol NJ, Szarka CE, Freedman G, Pinover W, Pingpank JF, Eisenberg BL. Trimodality therapy for advanced gallbladder cancer. Am Surg 2001;67:277-84.
• Sasson AR, Kim J. Many challenges of peritoneal carcinomatosis. J Oncol Pract 2017;13:435-6.
• Sasson AR, Ly QP, Are C. Surgical quality: more than just margins and lymph nodes. Gastrointest Cancer Res 2009;3:204-5.
• Sasson AR, Mulcahy MF, Paty PB. Update in the management of rectal cancer. American Society of Clinical Oncology Educational Book. 2006.
• Sasson AR, Pingpank JF Jr, Wetherington RW, Hanlon AL, Ridge JA. Incidental parathyroidectomy during thyroid surgery does not cause transient symptomatic hypocalcemia. Arch Otolaryngol Head Neck Surg 2001;127:304-8.
• Sasson AR, Sigurdson ER. Management of locally advanced rectal cancer. Surg Oncol 2000;9:193-204.
• Sasson AR, Sigurdson ER. Surgery of rectal cancer. In: Saltz LB, editor. Colorectal Cancer: Multimodality Management. Totowa, NJ: Humana Press, 2001: 337-56.
• Sasson AR, Sigurdson ER. Surgical treatment of liver metastases. Semin Oncol 2002;29:107-18.
• Sasson AR, Watson JC, Sigurdson ER. Hepatic artery infusional chemotherapy for colorectal liver metastases. In: Talamonti MS, Pappas SG, editors. Liver-Directed Therapy for Primary and Metastatic Liver Tumors. Norwell, MA: Kluwer, 2001: 279-98.
• Sasson AR, Wetherington RW, Hoffman JP, Ross EA, Cooper H, Meropol NJ, Freedman G, Pingpank JF, Eisenberg BL. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome. Int J Gastrointest Cancer 2003;34:121-8.
• Senapati S, Chaturvedi P, Chaney WG, Chakraborty S, Gnanapragassam VS, Sasson AR, Batra SK. Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer. Clin Cancer Res 2011;17:267-74.
• Shah BC, Ullrich F, Smith L, Leiphrakpam P, Ly Q, Sasson A, Are C. National trends in discharge disposition after hepatic resection for malignancy. HPB (Oxford) 2011;13:96-102.
• Sherman S, Shats O, Ketcham MA, Anderson MA, Whitcomb DC, Lynch HT, Ghiorzo P, Rubinstein WS, Sasson AR, Grizzle WE, Haynatzki G, Feng J, Sherman A, Kinarsky L, Brand RE. PCCR: Pancreatic Cancer Collaborative Registry. Cancer Inform 2011;10:83-91.
• Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ, Batra SK, Singh PK. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Oncotarget 2015;6:19118-31.
• Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim JW, Hankins JH, Weekes C, Hollingsworth MA, Sarkova NJ, Sasson AR, et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell 2017;32:71-87.e7.
• Singh S, Chakraborty S, Bonthu N, Radio S, Hussain SM, Sasson A. Combined hepatocellular cholangiocarcinoma: a case report and review of literature. Dig Dis Sci 2013;58:2114-23.
• Stade M, Sasson AR, Oleynikov D, Stothert J, Thompson J. Influence of pre-operative diagnosis and frozen section on operative management of pancreatic cystic lesions. HPB (Oxford) 2005;7:235-7.
• Sun FX, Sasson AR, Jiang P, An Z, Gamagami R, Li L, Moossa AR, Hoffman RM. An ultra-metastatic model of human colon cancer in nude mice. Clin Exp Metastasis 1999;17:41-8.
• Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB 3rd, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW 2nd, Malafa MP, Muscarella P 2nd, Nakakura EK, Sasson AR, et al.; NCCN Pancreatic Adenocarcinoma. Pancreatic adenocarcinoma. J Natl Compr Canc Netw 2010;8:972-1017.
• Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Sasson AR, et al.; National Comprehensive Cancer Networks. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2012;10:703-13.
• Tempero MA, Behrman S, Ben-Josef E, Benson AB 3rd, Cameron JL, Casper ES, Hoffman JP, Karl RC, Kim P, Koh WJ, Kuvshinoff BW 2nd, Melvin WS, Muscarella P 2nd, Sasson AR, et al.; National Comprehensive Cancer Network. Pancreatic adenocarcinoma: clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005;3:598-626.
• Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, et al. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2014;12:1083-93.
• Turaga K, Kaushik M, Forse RA, Sasson AR. In hospital outcomes after pancreatectomies: an analysis of a national database from 1996 to 2004. J Surg Oncol 2008;98:156-60.
• Van Buren G 2nd, Bloomston M, Schmidt CR, Behrman SW, Zyromski NJ, Ball CG, Morgan KA, Hughes SJ, Karanicolas PJ, Allendorf JD, Vollmer CM Jr, Ly Q, Brown KM, Velanovich V, Winter JM, McElhany AL, Muscarella P 2nd, Schmidt CM, House MG, Dixon E, Dillhoff ME, Trevino JG, Hallet J, Coburn NSG, Nakeeb A, Behrns KE, Sasson AR, et al. A prospective randomized multicenter trial of distal pancreatectomy with and without routine intraperitoneal drainage. Ann Surg 2017;266:421-31.
• Verma V, Lazenby AJ, Zheng D, Bhirud AR, Ly QP, Are C, Sasson AR, Lin C. Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: secondary analysis of a prospective clinical trial. Radiother Oncol 2017;122:464-9.
• Watley DC, Ly QP, Talmon G, Are C, Sasson AR. Clinical presentation and outcome of nonfunctional pancreatic neuroendocrine tumors in a modern cohort. Am J Surg 2015;210:1192-6.
• Wedel W, Talmon G, Sasson A. Nodular elastosis of the pancreas. Case Rep Pathol 2015;2015:521959.
> Click here to see abstracts/full text of Dr. Sasson's journal articles on PubMed (National Library of Medicine).

• Fellow, American College of Surgeons (FACS)
• Memberships
• American Hepato-Pancreato-Biliary Association
• American Society of Clinical Oncology
• Association for Academic Surgery
• Central Surgical Association
• International Society of Gastrointestinal Oncology
• Marshall J. Orloff Society
• Midwest Surgical Association
• North American Neuroendocrine Tumor Society
• Pancreas Club
• Society for Surgery of the Alimentary Tract
• Society of Surgical Oncology
• Southwestern Surgical Congress
• Research Groups
• Early Detection Research Network Pancreatic Cancer Working Group
• Gastrointestinal Spore: Inter-SPORE Clinical Committee
• Pancreatic Cancer Collaborative Registry (member, Steering Committee)
• Editorial Board
• World Journal of Gastrointestinal Surgery
• Reviewer
• American Journal of Surgery
• Annals of Surgery
• Anticancer Therapy
• Cancer Epidemiology
• Cancers
• Gastroenterology & Hepatology
• Gastrointestinal Cancer Research
• Journal of Clinical Oncology
• Journal of Surgical Oncology
• Journal of the American College of Surgeons
• Journal of the American Geriatrics Society
• Journal of the Pancreas
• Surgical Laparoscopy, Endoscopy & Percutaneous Techniques